Viridos

Viridos is a company that develops and commercializes genomic-driven solutions aimed at tackling global energy and environmental issues. It specializes in synthesizing and programming DNA to create and utilize technologies in synthetic genomics. The company designs and develops microbes for various industrial processes and environmental applications, including microbial cultivation technologies that identify novel microorganisms and new genes. Additionally, Viridos focuses on enhancing biofuel production, utilizing photosynthetic organisms to generate value-added products from sunlight and carbon dioxide, and improving the recovery rates of subsurface hydrocarbons. Its innovations also extend to the development of high-yield, disease-resistant feedstocks. Through these efforts, Viridos contributes to the production of energy, chemicals, and pharmaceuticals, while also promoting carbon sequestration and environmental remediation.

David C. Kiernan

Founder and Board of Directors

1 past transactions

Human Longevity

Series A in 2014
Founded in 2013, Human Longevity is a genomic-based health intelligence company headquartered in San Diego, California. It combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and empower proactive healthcare. The company's core offerings include the HLI Health Nucleus, which uses whole-genome sequence analysis and advanced clinical imaging to deliver comprehensive personal health insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.